Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
$0.40
-0.0200 ( -4.80% ) 75.9K
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Market Data
Open
$0.40
Previous close
$0.42
Volume
75.9K
Market cap
$32.18M
Day range
$0.40 - $0.43
52 week range
$0.13 - $1.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Nov 09, 2023 |
def | Proxies and info statements | 5 | Nov 08, 2023 |
8-k | 8K-related | 12 | Nov 03, 2023 |
8-k | 8K-related | 14 | Oct 24, 2023 |
4 | Insider transactions | 1 | Sep 05, 2023 |
8-k | 8K-related | 14 | Aug 14, 2023 |
10-q | Quarterly Reports | 48 | Aug 14, 2023 |
4 | Insider transactions | 1 | Aug 07, 2023 |
4 | Insider transactions | 1 | Aug 04, 2023 |
8-k | 8K-related | 17 | Jul 19, 2023 |